Name |
Serevent Inhaler 25 mikrograma/dozi, stlačeni inhalat, suspenzija |
Marketing Authorisation Number |
HR-H-899859080 |
Active Substance |
salmeterolksinafoat |
Composition |
jedna inhalacijska doza (ispuštena iz ventila) sadrži 25 mikrograma salmeterola u obliku salmeterolksinafoata |
Pharmaceutical Form |
stlačeni inhalat, suspenzija |
Manufacturer |
Glaxo Wellcome Production, Evreux, Francuska |
Marketing Authorisation Holder |
GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
Marketing Authorisation Date |
20.08.2021 |
MA Period of Validity |
unlimited |
Classification Number |
UP/I-530-09/15-02/404 |
Registration Number |
381-12-01/70-21-11 |
Prescription |
na recept |
Type of prescription |
ponovljivi recept
|
Distribution |
u ljekarni |
Advertising to general public |
zabranjeno |
ATC Code |
R03AC12 |
Medicinal product marketed in the Croatia |
Nestašica |
SmPC |
download |
PL |
download |